← Back to headlines
Boston Scientific Faces Growth Slowdown in Key Businesses
Boston Scientific (BSX) is reportedly experiencing a slowdown in growth across several of its core business segments, raising concerns about its future performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
FDA Approves Takeda’s Mimrylo for Treatment of Polycythemia Vera
36m ago
Banks Pause Sales of Products Linked to Mark Walter Amid Investigations
1h ago
Rating Agencies Maintain Stable Outlooks for French and Portuguese Sovereign Debt
1h ago
Canada’s Economy Rebounds With 3.3% Growth in Second Quarter
1h ago